Drug Type Enzyme |
Synonyms- |
Action inhibitors, agonists |
Mechanism IgA protease inhibitors(IgA protease inhibitors), Peptide hydrolase agonists(Peptide hydrolase agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glomerulonephritis, IGA | Preclinical | United States | 28 Sep 2024 |